| Primary |
| Drug Use For Unknown Indication |
34.6% |
| Product Used For Unknown Indication |
30.8% |
| Suicide Attempt |
11.5% |
| Orthostatic Hypotension |
7.7% |
| Anxiety |
3.8% |
| Confusional State |
3.8% |
| Depression |
3.8% |
| Psychotic Disorder |
3.8% |
|
| Death |
25.0% |
| Renal Failure Acute |
25.0% |
| Toxicity To Various Agents |
25.0% |
| Vomiting |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.5% |
| Drug Use For Unknown Indication |
20.0% |
| Psychotic Disorder |
8.6% |
| Schizophrenia |
6.8% |
| Depression |
5.2% |
| Anxiety |
4.4% |
| Agitation |
3.6% |
| Bipolar Disorder |
2.4% |
| Mental Disorder |
2.4% |
| Insomnia |
2.2% |
| Bipolar I Disorder |
1.7% |
| Drug Exposure During Pregnancy |
1.5% |
| Major Depression |
1.5% |
| Ill-defined Disorder |
1.3% |
| Delirium |
1.0% |
| Hallucination |
1.0% |
| Hypertension |
1.0% |
| Epilepsy |
0.8% |
| Pain |
0.8% |
| Hiv Infection |
0.7% |
|
| Somnolence |
8.3% |
| Vomiting |
7.9% |
| Rhabdomyolysis |
7.2% |
| Tachycardia |
7.2% |
| Vertigo |
6.5% |
| Thrombocytopenia |
5.8% |
| Suicide Attempt |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Treatment Noncompliance |
5.0% |
| Cytolytic Hepatitis |
4.7% |
| Tremor |
4.7% |
| Hepatitis Cholestatic |
4.0% |
| Psychotic Disorder |
4.0% |
| Cardiac Arrest |
3.6% |
| Colitis Ischaemic |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Parkinsonism |
3.6% |
| Pulmonary Embolism |
3.6% |
| Respiratory Distress |
3.6% |
| Hypotension |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.8% |
| Drug Use For Unknown Indication |
16.1% |
| Depression |
10.5% |
| Schizophrenia |
9.3% |
| Anxiety |
6.8% |
| Psychotic Disorder |
5.0% |
| Bipolar Disorder |
5.0% |
| Insomnia |
4.3% |
| Hiv Infection |
3.5% |
| Bipolar I Disorder |
2.7% |
| Hypertension |
2.4% |
| Schizophrenia, Paranoid Type |
2.1% |
| Abnormal Behaviour |
2.1% |
| Hepatitis C |
2.1% |
| Pain |
2.1% |
| Epilepsy |
2.0% |
| Agitation |
1.7% |
| Mental Disorder |
1.6% |
| Prophylaxis |
1.5% |
| Migraine |
1.4% |
|
| Vomiting |
9.1% |
| Rhabdomyolysis |
8.0% |
| Somnolence |
7.7% |
| Pulmonary Embolism |
7.3% |
| Weight Decreased |
7.0% |
| Off Label Use |
5.9% |
| Overdose |
5.9% |
| Weight Increased |
5.9% |
| Suicide Attempt |
5.6% |
| Thrombocytopenia |
5.6% |
| Cytolytic Hepatitis |
4.2% |
| Pyrexia |
3.8% |
| Hyponatraemia |
3.5% |
| Renal Failure |
3.5% |
| Tachycardia |
3.1% |
| Renal Failure Acute |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
| Transaminases Increased |
2.8% |
| Tremor |
2.8% |
| White Blood Cell Count Increased |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
46.7% |
| Insomnia |
12.6% |
| Product Used For Unknown Indication |
9.6% |
| Agitation |
7.2% |
| Aggression |
4.8% |
| Anxiety |
3.6% |
| Depression |
3.6% |
| Abnormal Behaviour |
2.4% |
| Hypertension |
1.8% |
| Prophylaxis |
1.8% |
| Psychotic Disorder |
1.8% |
| Schizophrenia |
1.8% |
| Epilepsy |
1.2% |
| Acute Lymphocytic Leukaemia |
0.6% |
| Affective Disorder |
0.6% |
|
| Drug Interaction |
13.3% |
| Insomnia |
13.3% |
| Rhabdomyolysis |
10.0% |
| Tachycardia |
10.0% |
| Epilepsy |
6.7% |
| Extrapyramidal Disorder |
6.7% |
| Sudden Death |
6.7% |
| Aptyalism |
3.3% |
| Death |
3.3% |
| Malaise |
3.3% |
| Off Label Use |
3.3% |
| Oral Disorder |
3.3% |
| Parkinsonism |
3.3% |
| Pneumonia Aspiration |
3.3% |
| Status Epilepticus |
3.3% |
| Vertigo |
3.3% |
| Vomiting |
3.3% |
|
